1-1 of 1
Susan O'Brien, BA, MD
Close
Sort by
Journal Articles

Bruton's Tyrosine Kinase Inhibitor PCI-32765 Abrogates BCR- and Nurselike Cell-Derived Activation of CLL Cells In Vitro and In Vivo.

Sabine Ponader, PhD, Joseph Buggy, PhD, Susan O'Brien, BA, MD, William G. Wierda, MD, PhD, Michael Keating, MD, Jan A. Burger, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 45.
https://doi.org/10.1182/blood.V116.21.45.45
Published: 2010